The increased proportion of patients with good neurological outcomes (i.e., CPC 1 and 2) at 90 days in the H 2 group (as compared to the control group) did not reach statistical significance.
← all excerpts
Efficacy of inhaled hydrogen on neurological outcome following brain ischaemia during post-cardiac arrest care (HYBRID II): a multi-centre, randomised, double-blind, placebo-controlled trial.
1
—
—